Clinical experience with liraglutide

Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India

CONTEXT GLP-1 receptor agonists (GLP-1 RA) are unique antidiabetic agents that have the ability to lower blood glucose without causing hypoglycemia, while at the same time promoting weight loss. Information on the efficacy and safety of GLP-1 RA in the Indian diabetic population is limited. AIMS (1) To evaluate the effect of GLP-1 RA, Liraglutide on glycemic control, and weight in obese India...

Clinical Experience with Aureomycin.

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)

STUDY QUESTION What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple daily insulin injections? METHODS The study was a randomised, double blind, placebo controlled trial with a parallel group design carried out at 13 hospital based outpatient clinics and one primary care unit in Sweden. Patients were conside...

Pancreatitis during treatment with liraglutide.

A 67-year-old man presented with a 10-day history of nausea, vomiting, and constant pain in the epigastrium which radiated to the sides. Five months before admission, liraglutide (1.2 mg/day) had been started in addition to metformin and gliclazide for the treatment of type II diabetes and the dose had been stable. His previous history was otherwise unremarkable; he did not report any acute or ...

Is treatment with liraglutide efficient?

In the current context of limited economic and health resources, efficiency of drug treatments is of paramount importance, and their clinical effects and related direct costs should therefore be analyzed. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for the treatment of type 2 diabetes mellitus (T2DM) which, in addition to its normoglycemic effects, induces a signi...